Trial intelligence / Profile preview

Dexmedetomidine-ketamine versus sevoflurane-sufentanil anesthesia in children with obstructive sleep apnea undergoing uvulopalatopharyngoplasty

ChiCTR-TRC-12002388Phase 4Completed

Sponsor
Shanghai Children's Medical Center
Start
Apr 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine, ketamine, sevoflurane and sufentanil in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: blood pressure, heart rate and 2 more. Started Apr 2012; status: completed.

02

Drugs

dexmedetomidineketaminesevofluranesufentanil
03

Conditions

obstructive sleep apnea hypopnea syndrome (OSAHS)

Beyond the preview

Go deeper on ChiCTR-TRC-12002388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call